NBIX

TYPE Stocks

GROUP Stocks

BASE Neurocrine B...

SECOND

<% (signals.list.current.rate).substr(0,7) %>

<% (signals.list.current.absolute).substr(0,9) %> (<% signals.list.current.percentage|toFixed:2 %>%)

MARKETS TREND

OPEN

<% (signals.list.current.openrate).substr(0,9) %>

HIGH

<% (signals.list.current.high).substr(0,9) %>

LOW

<% (signals.list.current.low).substr(0,9) %>

START TRADING

Multi Charts

Add to Watchlist

NBIX Signals

DON'T WANT TO MISS ANY SIGNAL? GO PREMIUM

ACCESS ALL FX, COMMODITIES & CRYPTO SIGNALS. GO PREMIUM

<% signal.pair %> (<% signal.rate %>) <% signal.action %>

<% signal.status %>

<% signal.analyst %>

Long Term

Entry Price

Stop Loss

Take Profit

<% signal.entryPrice %> N/A

PREMIUM ONLY

<% signal.stopLoss %> N/A

PREMIUM ONLY

<% signal.takeProfit %> N/A

PREMIUM ONLY

<% signal.comment %>

Description

<% signal.description %>

LATEST ANALYSIS

<% item.time_ago %> Ago

<% item.title %>

<% item.deltaTime %>

Full Analysis Feed

Last Updated: Jun 15, 2026 07:35:42 AM (GMT)

NBIX: The current live price is 158.11, reflecting a decrease of -1.76% from the previous price.

Support and Resistance Levels The pivot point is at 158.11, with current support levels at 158.11 and resistance levels at 158.11.

Indicators The current RSI is 13.02, indicating significant bearish momentum as it is falling. The ATR is 0.01286, indicating low volatility, while ADX stands at 76.63, suggesting a strong trend. The Parabolic SAR is at 159.93, and the price is below this. The EMA-5 is at 158.11, confirming a bearish trend.

Market Sentiment The market is bearish given the price is below the pivot point of 158.11, supported by the bearish indicators.

NBIX Signals & Technical Analysis

Last Updated: <% indicators.interval.updated|date:'MMM d, y h:mm:ss a' %>

Market Trend

Strong Sell

Sell

Neutral

Buy

Strong Buy

Loading Market Trend ...

Market Sentiment

BUY: <% indicators.sentiment.buy.length %> SELL: <% indicators.sentiment.sell.length %> NEUTRAL: <% indicators.sentiment.neutral.length %>

Strong Sell

Sell

Neutral

Buy

Strong Buy

Trend Indicators

NAME

VALUE

ACTION

Bollinger Bands

UPPER: <% indicators.data[indicators.interval.active].bbands.value.upper %>

MIDDLE: <% indicators.data[indicators.interval.active].bbands.value.middle %>

LOWER: <% indicators.data[indicators.interval.active].bbands.value.lower %>

Sell

Buy

Parabolic SAR

<% indicators.data[indicators.interval.active].sar.value %>

Sell

Buy

Standard Deviation

<% indicators.data[indicators.interval.active].stddev.value %>

High Volatility

Low Volatility

Oscillators

NAME

VALUE

ACTION

RSI(14)

<% indicators.data[indicators.interval.active].rsi.value %>

Sell

Buy

MACD(12,26)

<% indicators.data[indicators.interval.active].macd.value %>

Buy

Sell

Neutral

ATR

<% indicators.data[indicators.interval.active].atr.value %>

High Volatility

Low Volatility

STOCH(9,6)

<% indicators.data[indicators.interval.active].stochastics.value %>

Buy

Sell

ADX

<% indicators.data[indicators.interval.active].adx.value %>

High Volatility

Low Volatility

Moving Averages

PERIOD

SIMPLE

EXPONENTIAL

MA5

<% indicators.data[indicators.interval.active].sma5.value %> Buy Sell

<% indicators.data[indicators.interval.active].ema5.value %> Buy Sell

MA10

<% indicators.data[indicators.interval.active].sma10.value %> Buy Sell

<% indicators.data[indicators.interval.active].ema10.value %> Buy Sell

MA20

<% indicators.data[indicators.interval.active].sma20.value %> Buy Sell

<% indicators.data[indicators.interval.active].ema20.value %> Buy Sell

MA50

<% indicators.data[indicators.interval.active].sma50.value %> Buy Sell

<% indicators.data[indicators.interval.active].ema50.value %> Buy Sell

MA100

<% indicators.data[indicators.interval.active].sma100.value %> Buy Sell

<% indicators.data[indicators.interval.active].ema100.value %> Buy Sell

Pivot

PIVOT

CLASSIC

FIBONACCI

CAMARILLA

WOODIE

<% indicators.data[indicators.interval.active].pp.data.result.classic.s3 %>

<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.s3 %>

<% indicators.data[indicators.interval.active].pp.data.result.camarilla.s3 %>

<% indicators.data[indicators.interval.active].pp.data.result.woodie.s3 %>

<% indicators.data[indicators.interval.active].pp.data.result.classic.s2 %>

<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.s2 %>

<% indicators.data[indicators.interval.active].pp.data.result.camarilla.s2 %>

<% indicators.data[indicators.interval.active].pp.data.result.woodie.s2 %>

<% indicators.data[indicators.interval.active].pp.data.result.classic.s1 %>

<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.s1 %>

<% indicators.data[indicators.interval.active].pp.data.result.camarilla.s1 %>

<% indicators.data[indicators.interval.active].pp.data.result.woodie.s1 %>

<% indicators.data[indicators.interval.active].pp.data.result.classic.pp %>

<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.pp %>

<% indicators.data[indicators.interval.active].pp.data.result.camarilla.pp %>

<% indicators.data[indicators.interval.active].pp.data.result.woodie.pp %>

<% indicators.data[indicators.interval.active].pp.data.result.classic.r1 %>

<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.r1 %>

<% indicators.data[indicators.interval.active].pp.data.result.camarilla.r1 %>

<% indicators.data[indicators.interval.active].pp.data.result.woodie.r1 %>

<% indicators.data[indicators.interval.active].pp.data.result.classic.r2 %>

<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.r2 %>

<% indicators.data[indicators.interval.active].pp.data.result.camarilla.r2 %>

<% indicators.data[indicators.interval.active].pp.data.result.woodie.r2 %>

<% indicators.data[indicators.interval.active].pp.data.result.classic.r3 %>

<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.r3 %>

<% indicators.data[indicators.interval.active].pp.data.result.camarilla.r3 %>

<% indicators.data[indicators.interval.active].pp.data.result.woodie.r3 %>

About (NBIX) Neurocrine Biosciences Inc.

Company Background

Neurocrine Biosciences Inc. (NASDAQ: NBIX) is a biopharmaceutical company based in the United States that specializes in the development and commercialization of innovative treatments for neurological and endocrine disorders. Founded in 1992, Neurocrine is dedicated to improving the lives of patients through cutting-edge research and a commitment to advancing the science of medicine. The company's proprietary products and pipeline candidate focus on addressing critical unmet medical needs in a variety of therapeutic areas, including disorders related to the brain and hormonal systems.

Market Position

Neurocrine Biosciences has established itself as a leader in the biopharmaceutical industry, particularly in the field of neurology and endocrinology. The company's flagship product, Ingrezza (valbenazine), was approved by the FDA for the treatment of tardive dyskinesia, positioning Neurocrine as a pioneer in this therapeutic area. With a robust pipeline that includes compounds targeting Parkinson's disease, epilepsy, and other central nervous system disorders, Neurocrine is well-positioned to capitalize on the growing demand for advanced treatment options. The company maintains strategic partnerships and collaborations with various research institutions and organizations, enhancing its capabilities and market reach.

Key Financial and Industry Highlights

Neurocrine Biosciences has demonstrated strong financial performance, with significant revenue growth driven by its product portfolio, particularly from Ingrezza. The company reported impressive earnings results, reflecting its operational efficiency and commitment to R&D investment. Neurocrine's solid financial footing allows for continued investment in innovative therapies and the exploration of new treatment options. As the biopharmaceutical landscape evolves, Neurocrine remains committed to addressing pivotal healthcare challenges, with a focus on delivering breakthrough therapies that significantly enhance patient outcomes. The growing prevalence of neurological disorders presents a substantial opportunity for Neurocrine, reinforcing its market position as a key player in the biopharmaceutical sector.

Check all NBIX conversion rates

How to Buy or Trade Neurocrine Biosciences Inc. Stock (NBIX) with AvaTrade

Trading or investing in Neurocrine Biosciences Inc. stock through AvaTrade starts with opening a verified trading account. After registration, complete the KYC verification process by submitting your ID and proof of address, then fund your account using a supported payment method such as bank transfer, debit card, or e-wallet. Once your funds reflect, log into the AvaTrade platform or mobile app and search for the ticker symbol NBIX, which represents Neurocrine Biosciences Inc.. Before placing a trade, review the live Neurocrine Biosciences Inc. share price, market trend, spread, leverage options, and recent market news that could impact the stock price.

The next step is deciding whether you want to buy or sell Neurocrine Biosciences Inc. stock. Traders expecting the price to rise typically open a Buy position, while traders expecting weakness in the sector may open a Sell position using CFDs. Enter your preferred trade size, then apply risk management tools such as a stop-loss to limit downside exposure and a take-profit order to secure profits automatically. After confirming the trade, monitor key drivers including Neurocrine Biosciences Inc. earnings reports, product or service announcements, business segment performance, revenue growth, and overall stock market sentiment. Many traders also use technical indicators such as moving averages, RSI, and support/resistance levels available on the AvaTrade platform to improve timing and trading decisions.

Related Stocks

TLRY

Tilray Brands, Inc.

Industry Drug Manufacturers - Specialty & Generic

Exchange NASDAQ

CRON

Cronos Group Inc.

Industry Drug Manufacturers - Specialty & Generic

Exchange NASDAQ

ZTS

Zoetis Inc.

Industry Drug Manufacturers - Specialty & Generic

Exchange NYSE

NBIX